The company was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA. Never miss an important article again, stay on top of your investments and become a better investor today! join the STCK.PRO community and discover the power of social financial news! Copyright © 2020. Analyst ratings. Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Videos Stocktwits News. join the STCK.PRO community and discover the power of social financial news! Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Yahoo finance Google finance MarketWatch Robinhood. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. With our watchlist wall you can focus on other tasks without loosing track of your investments, don't worry we got you covered! Use of this site constitutes acceptance of our. in Medical - Pharmaceuticals. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Sign Up to See Ratings...FREE! The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. To see all exchange delays and terms of use, please see disclaimer. Thinking about buying stock in Northern Dynasty Minerals, Checkpoint Therapeutics, Rigel Pharmaceuticals, Vaxart, or Aytu Bioscience?  Industry Rank, Ranked of 240 We would like to remind you that the data contained in this website is not necessarily real-time nor accurate. Simply save our website to your homescreen and enjoy all the advantages of pogressive web apps. Rigel Pharmaceuticals, Inc. RIGL 2.69 0.07 (2.67%). Thinking about buying stock in Just Energy, Extreme Networks, Aurora Cannabis, AcelRx Pharmaceuticals, or Rigel Pharmaceuticals? NASDAQ: RIGL price review NASDAQ: RIGL price today. Description: Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Save time spend on researching stock which turn out to be a bummer! Description : Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. To increase the ergonomics of our platform (and because it just looks cool!) • 4 Coronavirus Stocks to Buy for the Second Wave, • 3 "Strong Buy" Dividend ETFs Yielding Over 5%. POWR Components: Trade Grade Buy & Hold Grade Peer Grade Industry Rank. Identify mispriced options in seconds with our userfriendly option chains. Rigel Pharmaceuticals, Inc. (RIGL) Today's Latest Price: $2.63 USD. See all "A" rated Strong Buy stocks. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Just enter your email address below. Sector Update: Health Care Firms Climb Pre-Bell Friday, Rigel Pharmaceuticals Enrolls First Patients in Study of COVID-19 Drug Candidate; Shares Gain Pre-Bell, Enrollment underway for Rigel Pharma's fostamatinib in mid-stage COVID-19 study, Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova, Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Path To Profitability, Rigel Announces Sponsored Mid-Stage Coronavirus Therapy Study, Return On Capital Employed Overview: Rigel Pharmaceuticals. Analyse in seconds if a stock is worth your time with our new easy to use stock analysis function. Want an app for your desktop? Featured Post From StockTwits … Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Find the latest Rigel Pharmaceuticals, Inc. (RIGL) stock quote, history, news and other vital information to help you with your stock trading and investing. Create watchlists and get real-time prices and news updates for all your watchlist symbols. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. Easy on the eyes withouth losing focus. Its products include Tavalisse, Fostamatinib and R835. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. Sign in.  Peer Grade Description : Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. Rigel Pharmaceuticals experienced mixed trading in 2019, but 2020 is off to a better start with the stock up about 30% year to date.A recent business update, which is digested in Find real-time RIGL - Rigel Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.